We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

26 hedge funds and large institutions have $1.9M invested in Lisata Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0.53% → 0.54% (+0.01%)

7% less funds holding

Funds holding: 28 → 26 (-2)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

33% less capital invested

Capital invested by funds: $2.85M → $1.9M (-$952K)

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
4
Calls
$68K
Puts
–
Net Calls
+$68K
Net Calls Change
-$27K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$193K
2
Deutsche Bank
Deutsche Bank
Germany
+$45.7K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$43.7K
4
VF
Virtu Financial
New York
+$34.4K
5
TRCT
Tower Research Capital (TRC)
New York
+$10.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$64.1K
2
STA
Summit Trail Advisors
New York
-$64K
3
TFO
Tarbox Family Office
California
-$42K
4
UBS Group
UBS Group
Switzerland
-$12K
5
RFC
Regions Financial Corp
Alabama
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$867K +$193K +4,333 +21%
Vanguard Group
2
Vanguard Group
Pennsylvania
$474K +$43.7K +983 +8%
Deutsche Bank
3
Deutsche Bank
Germany
$137K +$45.7K +1,029 +34%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$106K – – –
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$87K -$7.69K -173 -6%
BlackRock
6
BlackRock
New York
$66K -$64.1K -1,443 -43%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$38K – – –
VF
8
Virtu Financial
New York
$26K +$34.4K +775 New
Creative Planning
9
Creative Planning
Kansas
$23K – – –
WB
10
WesBanco Bank
West Virginia
$23K – – –
PAM
11
Panagora Asset Management
Massachusetts
$21K -$3.69K -83 -12%
Morgan Stanley
12
Morgan Stanley
New York
$11K -$6.49K -146 -31%
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$8K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$8K +$10.4K +234 New
Bank of America
15
Bank of America
North Carolina
$3K +$2.4K +54 +164%
Fifth Third Bancorp
16
Fifth Third Bancorp
Ohio
$2K – – –
Northwestern Mutual Wealth Management
17
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$1K – – –
RCAG
19
Rehmann Capital Advisory Group
Michigan
$25 – – –
KFS
20
Kelly Financial Services
Massachusetts
$23 – – –
RE
21
RBC Europe
United Kingdom
$23 – – –
STA
22
Summit Trail Advisors
New York
– -$64K -1,182 Closed
TFO
23
Tarbox Family Office
California
– -$42K -769 Closed
UBS Group
24
UBS Group
Switzerland
– -$12K -270 -100%
RFC
25
Regions Financial Corp
Alabama
– -$8K -149 Closed
1
2

LSTA Hedge Fund Activity: Q2 2019 in Review

26 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q2 2019, worth a combined $1.9M — down 33% from $2.85M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LSTA and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $193K. The largest seller was BlackRock, cutting an estimated $64.1K.

  • 26 institutional investors held Lisata Therapeutics (LSTA) as of Q2 2019, down from 28 in Q1 2019.
  • Funds reported $1.9M of Lisata Therapeutics stock for Q2 2019, down 33% quarter-over-quarter.
  • 3 funds opened new Lisata Therapeutics positions in Q2 2019 and 4 closed out, a net change of -1 holder.
  • The largest Lisata Therapeutics buyer in Q2 2019 was Renaissance Technologies, an estimated $193K added.
  • The largest Lisata Therapeutics seller in Q2 2019 was BlackRock, an estimated $64.1K sold.

Based on aggregated 13F filings for Q2 2019.